Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cidofovir Instillation in Hematopoietic Stem Cell Transplant (HSCT) Recipients With Hemorrhagic Cystitis

This study has been withdrawn prior to enrollment.
Sponsor:
Collaborator:
Gilead Sciences
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT00956176
First received: August 7, 2009
Last updated: September 5, 2012
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)